Chemed (CHE) Net Equity Issued and Repurchased (2009 - 2014)

Chemed has reported Net Equity Issued and Repurchased for 6 years, with the latest figure at $13.2 million in Q1 2014.

• Net Equity Issued and Repurchased for Q1 2014 came in at $13.2 million, up 29.75% year-over-year; the trailing twelve-month figure through Mar 2014 was $20.1 million (down 6.01% YoY), and the FY2013 annual result was $17.1 million, up 39.09% from the prior year.
• Net Equity Issued and Repurchased advanced to $13.2 million in Q1 2014, from $4.0 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $13.2 million in Q1 2014 and troughed at $57000.0 in Q4 2011.
• A 5-year average of $3.4 million and a median of $2.5 million in 2012 frame the typical range for Net Equity Issued and Repurchased.
• The widest annual swing landed in 2012, when Net Equity Issued and Repurchased surged 3105.26%; it then tumbled 91.68% in 2013.
• A 5-year view of Net Equity Issued and Repurchased shows it stood at $157000.0 in 2010, then tumbled by 63.69% to $57000.0 in 2011, then surged by 3105.26% to $1.8 million in 2012, then surged by 118.77% to $4.0 million in 2013, then jumped by 230.07% to $13.2 million in 2014.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $13.2 million in Q1 2014, $4.0 million in Q4 2013, and $567000.0 in Q3 2013.